Clinical Trial Update: Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated six versus twelve months of dual antiplatelet therapy after implantation of second-generation drug-eluting stents and has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Silent Ischemia

Drugs mentioned

• Second Generation Drug-Eluting Stents

Snippet

Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS | Conditions: Angina Pectoris, Silent Ischemia | Phase 3 | Status: TERMINATED